TCC2023 – It’s a wrap!
It’s a wrap for the 2nd edition of the [...]
The Tackle Cancer Challenge is back!
The Oncidium foundation is thrilled to announce that from [...]
February 2023 – The Third Edition of Radiotheranostics Today is out!
February 4th is World Cancer Day! Access for all in [...]
Thank you for your support!
Your support and contributions at the heart of the fight [...]
Doctor, will radiotheranostics make me radioactive?
You’ve been asking for it, and we did it! The [...]
EANM response to ASTRO’s framework for trainees
Letter to Editor for “European Association of Nuclear Medicine (EANM) [...]
Cost-Effectiveness Analysis of Lu-177-PSMA-617
Cost-Effectiveness Analysis of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant [...]
A major component to successfully establish radioligand therapy
Tackling the Last Mile: A major component to successfully establish [...]
Happy New Year !
From all of us at the Oncidium foundation to you [...]
European Commission approves Pluvicto™
European Commission Approves Pluvicto for PSMA-Positive mCRPC OncLive, Dec 14, [...]